Intrabone Cord Blood Transplantation

Hospital Clinic of Barcelona

Status and phase: Unknown; Phase 4

Conditions: Hematological Malignancies

Treatments: Procedure: Intrabone administration of umbilical cord blood

Study type: Interventional

Funder types: Other

Identifiers

NCT00838019

TPH/SCU-IMed 01/08

Details and patient eligibility

About

The purpose of this study is to evaluate the viability of intrabone administration of umbilical cord blood as allogenic transplantation for the treatment of hematologic malignancies.

Enrollment: 10 estimated patients

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hematological malignancies
• Indication of allogenic transplantation
• No suitable donor (related/unrelated)
• No suitable cord blood unit with enough cellularity for standard transplant
• Written informed consent

Exclusion criteria

• ECOG > 2
• Co-morbidities
• HIV positive serology
• Pregnancy or breastfeeding
• Psychiatric illness

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

10 participants in 1 patient group

Cord blood

Experimental group

Treatment:

Procedure: Intrabone administration of umbilical cord blood